| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
| Sales | 0 | 0 | 0 | 40 | 0 |
| Sales Growth | unch | unch | -100.00% | unch | unch |
| Net Income | -2,670 | -2,000 | -2,620 | -1,690 | -30,550 |
| Net Income Growth | -33.50% | +23.66% | -55.03% | +94.47% | -94.46% |
United Health Products Inc (UEEC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
United Health Products, Inc. develop, manufactures and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds and control bleeding. It serves dental and medical markets. United Health Products, Inc. is based in Henderson, Nevada.
Fiscal Year End Date: 12/31